Rhoen Klinikum AG (WBO:RHK) Other Stockholders Equity: €592 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:RHK Rhoen Klinikum AG WBO:RHK
81 GF Score
Price €12.80
GF Value €13.57
! 3 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG Other Stockholders Equity?

Rhoen Klinikum AG WBO:RHK +0.79% 81 Other Stockholders Equity is €592 Mil as of Mar. 2026. GuruFocus rates WBO:RHK with a GF Score™ of 81/100 and a GF Value™ of €13.57. The stock has 3 warning signs investors should review.

Rhoen Klinikum AG's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €592 Mil.

Rhoen Klinikum AG's quarterly Other Stockholders Equity increased from Sep. 2025 (€569 Mil) to Dec. 2025 (€579 Mil) and increased from Dec. 2025 (€579 Mil) to Mar. 2026 (€592 Mil).

Rhoen Klinikum AG's annual Other Stockholders Equity increased from Dec. 2023 (€511 Mil) to Dec. 2024 (€554 Mil) and increased from Dec. 2024 (€554 Mil) to Dec. 2025 (€579 Mil).

Rhoen Klinikum AG Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Rhoen Klinikum AG's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhoen Klinikum AG Other Stockholders Equity Chart

Rhoen Klinikum AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 456.82 482.30 510.54 554.43 579.13

Rhoen Klinikum AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 561.14 557.99 568.77 579.13 592.05
WBO:RHK
81GF Score
Rhoen Klinikum AG WBO:RHK
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhoen Klinikum AG Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €592 Mil mean?
Rhoen Klinikum AG (WBO:RHK) has a Other Stockholders Equity of €592 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Rhoen Klinikum AG and its competitors.
Is Rhoen Klinikum AG's Other Stockholders Equity too high?
Rhoen Klinikum AG's current Other Stockholders Equity is €592 Mil. Overall, Rhoen Klinikum AG has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Other Stockholders Equity compare to HCA and THC?
Rhoen Klinikum AG's Other Stockholders Equity of €592 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Rhoen Klinikum AG and its competitors. Rhoen Klinikum AG's current Other Stockholders Equity is €592 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current Other Stockholders Equity of €592 Mil. The stock's GF Value™ is €13.57, compared to a current price of €12.80 — trading 5.7% below its estimated fair value. The current Other Stockholders Equity is €592 Mil. Rhoen Klinikum AG's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current Other Stockholders Equity is €592 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued. The current stock price of €12.80 is trading 5.7% below its estimated GF Value™ of €13.57.

Key valuation signals for WBO:RHK:

  • Other Stockholders Equity: €592 Mil
  • GF Value™: €13.57 vs. price of €12.80 (5.7% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rhoen Klinikum AG Business Description

Other Exchanges 0NQH:UKRHK:Germany
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
81GF Score

Get the complete analysis for WBO:RHK

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.80
Price
€13.57
GF Value